Eligibility of monoclonal antibody-based therapy for patients with severe asthma: a Canadian cross-sectional perspective
Crossref DOI link: https://doi.org/10.1186/s13223-018-0301-6
Published Online: 2018-11-22
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jeimy, Samira http://orcid.org/0000-0002-3425-1874
Tsoulis, Michael William
Hachey, Julie
Kim, Harold
Text and Data Mining valid from 2018-11-22
Article History
Received: 6 July 2018
Accepted: 16 September 2018
First Online: 22 November 2018